Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
Publication|Articles|October 16, 2026
- October 2026
- Volume 92
- Issue 10
"I Don't Feel Anything Yet": Managing Patient Expectations About Medication Timelines
Author(s)Jeannette Y. Wick, RPh, MBA, FASCP
Fact checked by: Yasmeen Qahwash
Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
Advertisement
Advertisement
A patient starting buspirone returns several days later. “It isn’t doing anything,” she says. Another patient stops using an acne medication after
2 weeks because his skin has not cleared. A third decides that an antihypertensive is unnecessary because he feels exactly the same after taking it.
Related to this article
Pharmacists make a difference in patients’ lives through MTM services.
Each October, the pharmacy profession pauses to recognize technicians' decades-long evolution, from on-the-job trainees to nationally certified health care professionals.
At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.
Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.
A year after FDA approval in heart failure (HF) with LVEF of 40% or higher, new ACC guidance and trial subanalyses are shaping how pharmacists use finerenone.
Advertisement
Advertisement